The Food and Drug Administration (FDA) is proposing strict new regulations on laboratory-developed tests (LDTs). Once enacted, these rules could have significant harmful effects on clinical microbiology laboratories and the patients they serve.
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
